Stocky turns companies like Evolent Health, Inc into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Avoid. EVH's 28.5 Growth Compounder Score reflects modest revenue expansion insufficient to justify equity risk, while its 24 Value Compounder Score offers no compensating margin of safety. The core vulnerability: material dependence on government healthcare programs (Medicare, Medicaid, ACA) plus partner contracts terminable without cause on 30–180 days' notice creates structural instability that Leadership Alignment (38.3/100) cannot offset.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Evolent Health, Inc:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 37/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Evolent Health, Inc (EVH) at 37/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. EVH's 28.5 Growth Compounder Score reflects modest revenue expansion insufficient to justify equity risk, while its 24 Value Compounder Score offers no compensating margin of safety. The core vulnerability: material dependence on
EVH's current Stocky Verdict is 37/100, placing it in the "Avoid" band. This composite combines a 29/100 Compounder score, 38/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Evolent Health, Inc yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Evolent Health, Inc scores 38/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Evolent Health, Inc's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Evolent Health, Inc.
Sign up free and unlock the full analysis on EVH — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for EVH in the app.
